Home / Health / Cannabis Drug for Back Pain Hits Germany, Austria
Cannabis Drug for Back Pain Hits Germany, Austria
10 Jun
Summary
- A cannabis-derived drug for lower back pain is launching.
- The medicine is set to go on sale soon in Germany and Austria.
- The developer sees this as a test run before a US market launch.
A groundbreaking cannabis-derived medication targeting lower back pain is slated for release in Germany and Austria. Vertanical GmbH, a privately held German company, has secured regulatory approval for this innovative treatment. The firm considers this initial market entry a vital preliminary phase.
This launch serves as a strategic test before potentially entering the much larger and highly competitive United States pharmaceutical sector. The company aims to gather essential market data and user feedback from its German and Austrian rollout.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
